Association of smoking and alcohol use with rifampin-resistant TB treatment outcomes

Int J Tuberc Lung Dis. 2023 Apr 1;27(4):338-340. doi: 10.5588/ijtld.22.0678.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antitubercular Agents / therapeutic use
  • Humans
  • Isoniazid
  • Mycobacterium tuberculosis*
  • Rifampin / therapeutic use
  • Smoking / adverse effects
  • Smoking / epidemiology
  • Treatment Outcome
  • Tuberculosis, Multidrug-Resistant* / drug therapy

Substances

  • Rifampin
  • Antitubercular Agents
  • Isoniazid